FRESENIUS K@HOME HEMO W/ PRIME BAG 03-2962-3

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2016-05-04 for FRESENIUS K@HOME HEMO W/ PRIME BAG 03-2962-3 manufactured by Fresenius Medical Care North America.

Event Text Entries

[44893200] (b)(4). The complaint device was not returned for analysis; however, a companion sample from the same lot was made available to the manufacturer for physical evaluation and a functional analysis. A visual examination was performed on the tubing set and drainage bag of the companion sample; no defects were identified. The companion sample was then tested using a 2008t hemodialysis machine for simulated use. The bloodline was able to be primed with no visible issues. During the simulated use test, fluid flowed through the lines without issue. No alarms were generated and there were no observations of a frothy fluid or any other foreign matter in the venous chamber during the simulated use test. The device worked as intended with no noted abnormalities and no defects identified. A records review was performed on the reported lot. An investigation of the device manufacturing records was conducted by the manufacturer. There were no deviations or non-conformances during the manufacturing process. In addition, the batch record review confirmed the labeling, material, and process controls were within specification. The investigation into the cause of the reported problem was not able to confirm the failure mode. The reported defect of frothy fluid identified in venous chamber was not duplicated. The evaluation of the companion sample confirmed that the devices functioned fully as designed and met specification.
Patient Sequence No: 1, Text Type: N, H10


[44893201] A user facility home hemodialysis nurse reported that approximately one hour into a patient's home hemodialysis (hd) treatment, a venous pressure alarm occurred. Reportedly, a clear frothy fluid was observed in the venous chamber by the patient's spouse. The treatment was terminated without rinsing back the blood within the bloodline circuit. The patient's estimated blood loss (ebl) was approximately 200cc. No adverse effects were experienced by the patient as a result of this event and no medical intervention was required. The complaint device is not available for evaluation, however, the user facility provided a companion sample to the manufacturer.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number8030665-2016-00210
MDR Report Key5630379
Date Received2016-05-04
Date of Report2016-05-04
Date of Event2016-02-16
Date Mfgr Received2016-02-17
Device Manufacturer Date2015-07-10
Date Added to Maude2016-05-04
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactCNOR TANYA TAFT
Manufacturer Street920 WINTER ST.
Manufacturer CityWALTHAM MA 02451
Manufacturer CountryUS
Manufacturer Postal02451
Manufacturer Phone7816999000
Manufacturer G1ERIKA DE REYNOSA, S.A. DE C.V.
Manufacturer StreetMIKE ALLEN #1331 PARQUE INDUSTRIAL REYNOSA
Manufacturer CityREYNOSA, TAMAULIPAS CP 88780
Manufacturer CountryMX
Manufacturer Postal Code88780
Single Use3
Previous Use Code3
Event Type3
Type of Report0

Device Details

Brand NameFRESENIUS K@HOME HEMO W/ PRIME BAG
Generic NameHIGH PERMEABILITY HEMODIALYSIS SYSTEM FOR AT HOME USE
Product CodeONW
Date Received2016-05-04
Returned To Mfg2016-04-06
Catalog Number03-2962-3
Lot Number15JR01234
ID Number00840861100330
Device Expiration Date2018-07-31
OperatorLAY USER/PATIENT
Device AvailabilityR
Device Eval'ed by Mfgr*
Device Sequence No1
Device Event Key0
ManufacturerFRESENIUS MEDICAL CARE NORTH AMERICA
Manufacturer AddressMIKE ALLEN #1331 PARQUE INDUSTRIAL REYNOSA REYNOSA, TAMAULIPAS CP 88780 MX 88780


Patients

Patient NumberTreatmentOutcomeDate
10 2016-05-04

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.